Hematological Alterations after Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

Background: Cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) have benefits for survival in some cancers with peritoneal metastasis. Hematologic toxicity described rate is 2 to 38%. Methods: Patients admitted to an intensive care unit (ICU) after CRS and HIPEC over 78...

Descripción completa

Detalles Bibliográficos
Autores principales: Pintado, Maria Consuelo, Lasa Unzúe, Inmaculada, Gómez Sanz, Remedios, Diez Alonso, Manuel, Ortega, Miguel A., Álvarez de Mon, Melchor, Nevado Losada, Emilio, Gutierrez Calvo, Alberto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342859/
https://www.ncbi.nlm.nih.gov/pubmed/37445361
http://dx.doi.org/10.3390/jcm12134323

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10342859/
https://www.ncbi.nlm.nih.gov/pubmed/37445361
http://dx.doi.org/10.3390/jcm12134323

Ejemplares similares